<- Go Home

Paragon 28, Inc.

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair system, and phantom fibula nail system. It also provides flatfoot systems, such as gorilla universal plating system, JAWS great white staple system, monster screw system, grappler suture anchor system, and mister tendon harvester system; ankle replacement system consists of metallic and plastic implant components, as well as ankle fusion plating system and phantom hindfoot nailing system; Charcot systems, including the joust beaming system, gorilla medial column plating system, and monkey rings external fixation system; and orthobiologics products, such as V92 cellular bone matrix, PRESERVE bone wedges, MgNum bone void filler, and BEAST demineralized bone matrix. The company serves hospitals, ambulatory surgery centers, and health care facilities through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado. As of April 21, 2025, Paragon 28, Inc. operates as a subsidiary of Zimmer Biomet Holdings, Inc.

Market Cap

$1.1B

Volume

601.0K

Cash and Equivalents

$34.6M

EBITDA

-$22.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$191.5M

Profit Margin

74.75%

52 Week High

$13.13

52 Week Low

$4.65

Dividend

N/A

Price / Book Value

8.41

Price / Earnings

-19.83

Price / Tangible Book Value

12.95

Enterprise Value

$1.2B

Enterprise Value / EBITDA

-54.81

Operating Income

-$40.8M

Return on Equity

36.39%

Return on Assets

-8.18

Cash and Short Term Investments

$34.6M

Debt

$112.6M

Equity

$130.6M

Revenue

$256.2M

Unlevered FCF

-$15.7M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches